Field-Ready, Automated Cepheid TB Test Shows Promise In Developing World

Cepheid's Xpert MTB/RIF automated nucleic acid-amplification tuberculosis and rifampin-resistance test may be a "game changer" in effectively treating TB cases in the developing world, according to a study and editorial in the Sept. 1 New England Journal of Medicine